Literature DB >> 4469361

The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patients.

W T Carpenter, J S Strauss, J J Bartko.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4469361     DOI： 10.1093/schbul/1.11.37

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  10 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

2.  A comparison of schizophrenic patients in different community support treatment approaches.

Authors:  D L Cutler; E Tatum; J H Shore
Journal:  Community Ment Health J       Date:  1987

Review 3.  Poor insight in schizophrenia.

Authors:  X F Amador; D H Strauss
Journal:  Psychiatr Q       Date:  1993

4.  Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.

Authors:  R P Ebstein; J Biederman; R Rimon; J Zohar; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

5.  Amphetamine psychosis and psychotic symptoms.

Authors:  D S Janowsky; C Risch
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

6.  Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unit.

Authors:  Tomohiro Takehara; Tetsuo Tani; Hiroyuki Takiue; Ryo Takeshita; Arifumi Iwamaru; Tatsuya Yamamoto; Hidefumi Koh
Journal:  Mol Clin Oncol       Date:  2020-01-10

7.  Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task.

Authors:  Daniel Scott; Jane R Taylor
Journal:  Behav Brain Res       Date:  2013-11-14       Impact factor: 3.332

8.  Human platelet function as a model for investigating the clinical efficacy of chlorpromazine.

Authors:  M B Youdim; A Hefez; B Oppenheim
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

9.  A review of reward processing and motivational impairment in schizophrenia.

Authors:  Gregory P Strauss; James A Waltz; James M Gold
Journal:  Schizophr Bull       Date:  2013-12-27       Impact factor: 9.306

10.  What is Missing in Treatment Guidelines?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.